Purexa Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Purexa General Information
Description
Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug trials. The company's columns are used for the downstream purification of a range of therapeutic agents that include monoclonal antibodies, recombinant and fusion proteins, enabling researchers to improve the speed of early-stage development to get biologics to market where they are needed, to serve growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases and autoimmune disorders.
Contact Information
Website
www.purexa.com(Operating Subsidiary)
Corporate Office
- 215 Innovation Drive
- Suite D
- Greenville, SC 29607
- United States
Corporate Office
- 215 Innovation Drive
- Suite D
- Greenville, SC 29607
- United States
Purexa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 29-Apr-2025 | Completed | Generating Revenue | |||
| 8. Merger/Acquisition | 13-Jun-2022 | Completed | Generating Revenue | |||
| 7. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 6. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 5. Grant | 30-Aug-2018 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2016 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 16-Apr-2015 | Completed | Startup | |||
| 1. Grant | $80K | Completed | Startup |
Purexa Comparisons
Industry
Financing
Details
Purexa Competitors (16)
One of Purexa’s 16 competitors is Cellectis, a Formerly VC-backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellectis | Formerly VC-backed | Paris, France | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Cell Signaling Technology | Corporation | Danvers, MA | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ |
Purexa Patents
Purexa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230010637-A1 | Epoxide-activated substrates and hydrophobic interaction chromatography made therefrom for polynucleotide purification | Pending | 12-Jul-2021 | ||
| WO-2022104197-A1 | Methods of oligonucleotide-based affinity chromatography | Inactive | 13-Nov-2020 | ||
| JP-2022512344-A | Affinity film and manufacturing method | Active | 12-Dec-2018 | ||
| WO-2020123714-A1 | Affinity membrane and method of preparation | Inactive | 12-Dec-2018 | B01J20/3274 |
Purexa Signals
Purexa Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clemson University Foundation | Limited Partner | |||
| Groupe Michelin | Corporation | |||
| National Institute of General Medical Sciences | Government | |||
| National Institutes of Health | Government | |||
| SC EPSCoR/IDeA Foundation | Government |
Purexa FAQs
-
When was Purexa founded?
Purexa was founded in 2013.
-
Where is Purexa headquartered?
Purexa is headquartered in Greenville, SC.
-
What is the size of Purexa?
Purexa has 11 total employees.
-
What industry is Purexa in?
Purexa’s primary industry is Drug Discovery.
-
Is Purexa a private or public company?
Purexa is a Private company.
-
What is Purexa’s current revenue?
The current revenue for Purexa is .
-
Who are Purexa’s investors?
Clemson University Foundation, Groupe Michelin, National Institute of General Medical Sciences, National Institutes of Health, and SC EPSCoR/IDeA Foundation are 5 of 10 investors who have invested in Purexa.
-
Who are Purexa’s competitors?
Cellectis, Gilead, Cell Signaling Technology, Abcam, and Bristol-Myers Squibb are some of the 16 competitors of Purexa.
-
When was Purexa acquired?
Purexa was acquired on 29-Apr-2025.
-
Who acquired Purexa?
Purexa was acquired by Donaldson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process